17
2025
-
03
Koyuan Pharmaceutical & Liny Pharmaceutical Shine at the 2025 Xiding Conference, Discussing the New Future of the Pharmaceutical Industry!
Classification:
News
行业新闻
Corporate News
15On a spring-filled day in Huzhou, the grand opening of the 2025 Xiding Conference (China Pharmaceutical and Health Industry Business Cooperation Conference) was celebrated. Koyuan Pharmaceutical (Stock Code: 301281.SZ) & Linov Pharmaceutical were invited to exhibit, joining industry partners in discussing the bright future of the pharmaceutical industry. A product-themed song and dance performance was presented at the business luncheon on the 16th, offering industry colleagues an audiovisual feast combining innovation and strength.

As the annual pharmaceutical industry event, the Xiding Conference brings together business elites, industry experts, and partners from all parts of the industrial chain across the country. It serves as an important platform to promote exchange, cooperation, and innovative development within the pharmaceutical industry. Linov Pharmaceutical, a wholly-owned subsidiary of Koyuan Pharmaceutical—a leading domestic chemical raw material drug company—leverages its integrated raw material and preparation advantages to provide high-quality pharmaceutical products and services to patients worldwide.


The company's booth was bustling with activity, attracting numerous industry professionals for visits, exchanges, and cooperation discussions. Many partners showed strong interest in the products of Koyuan Pharmaceutical & Linov Pharmaceutical, expressing their willingness to collaborate further. This laid a solid foundation for the company to expand its market and deepen its industrial layout in the new year.

During the luncheon, Koyuan Pharmaceutical & Linov Pharmaceutical showcased key products through song and dance: Amiloride paste, isosorbide dinitrate spray, ferric protein succinate oral solution, and ambroxol hydrochloride drops for children's coughs.

This event was not only a product showcase but also a demonstration of the corporate spirit and innovative ideas of Koyuan Pharmaceutical & Linov Pharmaceutical. The unique song and dance performance integrated product introductions, breaking away from the traditional, monotonous product presentation model. This lighthearted and engaging approach allowed attendees to deeply appreciate the characteristics and advantages of the products, earning high praise from the guests and adding a unique highlight to the Xiding Conference.

Xiding appointment, safeguarding a healthy future! Koyuan Pharmaceutical & Linov Pharmaceutical will continue to uphold the corporate mission of “guarding life and health with digital medicine,” increasing R&D investment, deepening industry-academia-research cooperation, and continuously launching more high-quality and innovative pharmaceutical products. At the same time, the company will continue to leverage industry platforms such as the Xiding Conference to actively participate in industry exchanges and cooperation, working together with colleagues from all walks of life to explore the new future of the pharmaceutical industry and contribute to the construction of a healthy China.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD:#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China